Dendreon Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 6 of 6 Posts
E Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Article By: Terry Chrisomalis Monday, February 23, 2015 8:05 PM EDT
Valeant has agreed to acquire Salix For $10.4 billion or $158 per share in an all cash deal.
In this article: VRX, SLXP, DNDN, AGN, ACT
Read
Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital's Stephen Dunn
Article By: The Life Sciences Report Monday, February 23, 2015 3:42 PM EDT
Immuno-oncology took center stage in the drug development world in 2014. But can this preeminence continue in 2015? In this interview, Stephen Dunn of LifeTech Capital outlines how companies are leveraging these therapies, and where investors should look for opportunity in the sector.
In this article: MRK, BMY, RHHBY, ESRX, PFE, MKGAY, AZN, KITE, JUNO, NVS, DNDN, JNJ, AMGN, XON, ZIOP, CBMG
Read
E Dendreon Files For Bankruptcy, Stock Tanks
Article By: Terry Chrisomalis Monday, November 10, 2014 6:47 PM EDT
Dendreon files for Chapter 11 bankruptcy after disappointing sales for Provenge
In this article: JNJ, DNDN, MDVN
Read
Biotech Stocks: The Sector's Most Comprehensive Immunotherapy Platforms
Article By: BioMedReports Friday, November 7, 2014 4:58 AM EDT
The National Cancer Institute (NCI) spends upwards of $4.9 billion each year on cancer research.
In this article: INO, NWBO, TPIV, DNDN, GALE
Read
Frontrunning: June 10
Article By: Tyler Durden Tuesday, June 10, 2014 9:05 AM EDT
Ukraine, Russia Fail to Reach Deal in Natural-Gas Talks (WSJ). Boko Haram Kidnaps More Girls in Nigeria (WSJ). Déjà vu: echoes of pre-crisis world mount (FT)...
In this article: ALEX, ALU, AMD, BLT, CCE, CL, CS, CVX, DEO, DUK, GM, MRK, TOT, TSN, TWC, WMT, XOM, DNDN, IDIX, BEAV, EBAY, FB
Read
E Today's DailyTalk
Article By: TalkMarkets DailyTalk Thursday, October 31, 2013 3:59 PM EDT
Here's what we're reading. It's all good.
In this article: DNDN, GOOG, ORCL, RHT NOW IBM
Read
1 to 6 of 6 Posts